Last reviewed · How we verify
Standard full-volume PEG
The standard full-volume polyethylene glycol (PEG) solution is used for bowel preparation before colonoscopy. It is not an FDA-approved product but is commonly used in clinical practice. The solution works by inducing a rapid and thorough cleansing of the bowel through osmotic action, ensuring that the colon is clear for effective visualization during the procedure. Despite its widespread use, there is no specific FDA label for this formulation, and it is often prepared and administered according to institutional protocols. Common side effects include nausea, bloating, and abdominal cramps, which are generally mild to moderate in severity.
At a glance
| Generic name | Standard full-volume PEG |
|---|---|
| Sponsor | Kyunghee University Medical Center |
| Drug class | Osmotic laxative |
| Target | Intestinal lumen |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial. (NA)
- Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
- Bowel Preparation for Colonoscopy in the Elderly (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard full-volume PEG CI brief — competitive landscape report
- Standard full-volume PEG updates RSS · CI watch RSS
- Kyunghee University Medical Center portfolio CI